India, Jan. 29 -- The Yamuna Expressway Industrial Development Authority (Yeida) on Wednesday said it has issued a letter of intent (LoI) to Shukra Pharmaceuticals for allotment of 10 acres of land under its Medical Device Park project in Sector 28.

The Yeida handed over the letter on Tuesday in the presence of Yeida CEO Rakesh Kumar Singh, additional CEO Shailendra Bhatia and senior representatives of Shukra Pharmaceuticals, including group CEO and global head Dr Minakshi Late, COO Gaurav Shokeen, vice-president Anil Kumar Verma and business unit head Kamini Bharti.

"Shukra Pharmaceuticals plans to set up an advanced manufacturing facility focused on high-end and life-saving medical technologies. A key component will be the production ...